Nevirapine-induced neuropsychiatric complications, a class effect of non-nucleoside reverse transcriptase inhibitors? [2]

AIDS

Volumn 16, Issue 13, 2002, Pages 1840-1841

  Morlese, John F ^a   Qazi, Nadeem A ^a   Gazzard, Brian G ^a   Nelson, Mark R ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIDANOSINE; LAMIVUDINE; NELFINAVIR; NEVIRAPINE; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; TENOFOVIR;

ADULT; CASE REPORT; DREAM; DROWSINESS; HEADACHE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; MALE; MENTAL DISEASE; NIGHTMARE; PRIORITY JOURNAL; PSYCHOSIS; SOMNOLENCE;

ADULT; ANTI-HIV AGENTS; DREAMS; DRUG THERAPY, COMBINATION; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; NEVIRAPINE; REVERSE TRANSCRIPTASE INHIBITORS; SLEEP DISORDERS;

EID: 0037032035     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200209060-00023     Document Type: Letter

References (8)

1. Prime K, French P. Neuropsychiatric reaction induced by clarithromycin in a patient on highly active antiretroviral therapy (HAART). Sex Transm Infect 2001, 77:297-298.
2. Boehringer Ingelheim International. Viramune: summary of product characteristics. Available from http://www.edura.org/humans/EPAR/Viramune/Viramune.htm. April 2000.
3. Tashima KT, Caliendo AM, Ahmad M, et al. Cerebrospinal fluid human immunodefiency virus type-1 (HIV-1) suppression and efavirenz drug concentrations in HIV-1 infected patients receiving combination therapy. J Infect Dis 1999, 180:862-864.
4. Nakayama H, Nakano Y, Itoh N, Koike R, Honma A, Takahashi M, Gotoh T. A case of Castleman's disease with a variable neuropsychiatric symptomatology. No To Shinkei 1992, 44: 923-928.
5. Renault PF, Hoofnagle JH, Park Y, et al. Psychiatric complications of long-term interferon alpha therapy. Arch Intern Med 1987, 147:1577-1580.
6. Renault PF, Hoofnagle JH. Side effects of alpha interferon. Semin Liver Dis 1989, 9:273-277.
7. Denicoff KD, Rubinow DR, Papa MZ, et al. The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells. Ann Intern Med 1987, 107:293-300.
8. Thompson DF, Pierce DR. Drug-induced nightmares. Ann Pharmacother 1999, 33:93-98.